Changes of coronary risk factors after eradication of Helicobacter pylori infection

Ye-Hsu Lu1, Hsueh-Wei Yen, Tsung-Hsien Lin

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan.

Insights

Eradicating Helicobacter pylori (HP) infection did not significantly alter coronary risk factors like blood sugar, lipids, or fibrinolytic profiles in patients. Further research is needed to clarify the link between HP infection and coronary artery disease.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Epidemiology

Background:

  • Epidemiological studies suggest a link between Helicobacter pylori (HP) infection and coronary artery disease.
  • Previous research indicates potential associations between HP infection and coronary risk factors.
  • Limited and conflicting clinical data exist on risk factor changes post-HP eradication.

Purpose of the Study:

  • To prospectively evaluate changes in sugar, lipid, and fibrinolytic profiles after successful HP eradication.
  • To investigate the impact of HP eradication on established coronary risk factors.

Main Methods:

  • Prospective study involving 48 patients with confirmed gastric HP infection.
  • HP eradication using a standard omeprazole-amoxicillin-clarithromycin (OAC) regimen.
  • Measurement and comparison of pre- and post-eradication blood sugar, lipid profiles, and fibrinolytic markers.

Main Results:

  • Successful eradication of HP infection was confirmed in all participants.
  • No statistically significant changes were observed in fasting blood sugar levels post-treatment.
  • Lipid profiles (total cholesterol, HDL, LDL, triglycerides) and fibrinolytic profiles (t-PA, PAI-1, fibrinogen, D-dimer) remained unchanged after HP eradication.

Conclusions:

  • Successful eradication of Helicobacter pylori does not appear to modify key coronary risk factors.
  • The relationship between HP infection and coronary artery disease requires further investigation.
  • Current findings suggest that HP eradication alone may not be sufficient to alter cardiovascular risk profiles.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...